On September 25, 2018 Aduro Biotech, Inc. (NASDAQ: ADRO) reported that Stephen T. Isaacs, chairman, president and chief executive officer of Aduro, will present at the following upcoming investor conferences (Press release, Aduro Biotech, SEP 25, 2018, View Source;p=RssLanding&cat=news&id=2368930 [SID1234529583]):
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Cantor Fitzgerald 2018 Global Healthcare Conference in New York, NY on Tuesday, October 2, 2018 at 3:25pm Eastern Time
Leerink Partners Roundtable Series: Rare Disease & Oncology in New York, NY on Wednesday, October 3, 2018 at 8:00am Eastern Time
To access the live webcast and subsequent archived recording of this and other company presentations, please visit Aduro’s website at www.aduro.com.